@jameslarkin13
Research interests: the marketing practices of the pharmaceutical & medical device industries, multimorbidity, out-of-pocket payments. RCSI Postdoctoral fellow https://www.researchgate.net/profile/James-Larkin-2
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review
link.springer.com/article/10.1...
Mohammed Gharbia, Lydia Iladiva, @frankmoriarty.bsky.social, Tom Fahey & @jameslarkin13.bsky.social
Our current systems for research assessment are narrow and flawed - @ginnybarbour.bsky.social
@aimosinc.bsky.social
#AIMOS2025
A key strategy of commercial actors is to influence and distort the evidence base relating to the harms of their products
This is done through funding misleading industry-friendly science & through the active promotion of misinformation
@markpetticrew.bsky.social
@aimosinc.bsky.social
#AIMOS2025
"I'm not influenced."
"My colleagues are influenced, but I'm not."
"I have ties with all the, companies, so I'm not influenced by any.”
Lisa Bero describing the ways people rationalise their conflicts of interest, opening the #AIMOS2025 conference
@aimosinc.bsky.social
Misinformation about health is flooding social media, exposing the limits of current regulations and interventions. In this scoping review, we highlight key challenges and gaps in the current landscape: ebm.bmj.com/content/earl... @brookenickel.bsky.social @sydney.edu.au @ucph.bsky.social
sign up sign up
come along to our first event 31st october or add yourself to our mailing list for a streamed section of the day. it's going to be excellent. no sponsorship, independent, and amazing people are coming medicine.st-andrews.ac.uk/centreforevi...
🚨Publication🚨
Grateful to be part of this publication with @mgtmccartney.bsky.social and colleagues
Take home: lots of hormone replace therapy social media claims don't align with best practice recommendations. And lots of the posters have conflicts of interest.
Full study: tinyurl.com/2rxpfwnr
Less inequality = fewer problems
@profkepickett.bsky.social lays our her vision for a good society at #SSM2025
@socsocmed.bsky.social
Research by alcohol industry funded organisations like DrinkAware often distorts health evidence
In that context, Alice Thompson presents on alcohol industry funded research on drink spiking
#SSM2025
@socsocmed.bsky.social
@markpetticrew.bsky.social
@maizie333.bsky.social
@spidermaani.bsky.social
There is nowhere safe to go in Gaza.
Israeli forces have ordered thousands of Palestinians in Gaza City to evacuate as the military prepares another major assault.
States should act to prevent genocide in Gaza and press Israel to reverse course.
Do unhealthy commodity advertising restrictions affect energy consumption, have unintended effects and are there loopholes?
Great presentation by @frankdv.bsky.social discussing his evaluation of the Bristol unhealthy commodity advertising restrictions
#SSM2025
@socsocmed.bsky.social
“Advertising is one of most effective ways of promoting harmful commodity use”
Excellent presentation by @michaelpdaly.bsky.social on what policy restrictions local authorities place on harmful commodity advertising, & what factors impede or facilitate these policies
#SSM2025
@socsocmed.bsky.social
Pharmaceutical payments to general practices rose from £2.5 mill in 2015 to £7.5 mill in 2022. 54 companies made payments, but one company, Chiesi—marketing respiratory inhalers—accounted for >50% of payments since 2017
The payment growth and the dominance of one company raise concerns about bias
"Patient Partnership Week has been sponsored by Abbott, Amgen, AstraZeneca & Novartis" www.patients-association.org.uk/news/patient...
Our commentary on commercial influences on patient & public involvement ➡️ academic.oup.com/heapro/artic...
@jameslarkin13.bsky.social @healthpromint.bsky.social
"The patient and the State must know that there is no bias in the system." Gillian Toole TD
www.oireachtas.ie/en/debates/d...
"Transfers of value can create conflicts of interest, and I understand that some international research has linked them to higher prescribing rates, higher costs and lower prescribing quality." - Kieran O'Donnell TD
"The significant consequences of poorly managed conflicts of interest in healthcare have been highlighted in many countries. Examples include the US opioid epidemic[...] and the pelvic mesh scandal in Britain." - Darren O'Rourke TD
Yesterday the Dáil debated legislation to legally mandate public disclosure of payments from pharmaceutical & medical device company payments to healthcare professionals and healthcare organisations. It was refreshing to hear insightful contributions from government and opposition TDs
thread: 1/4
Thanks Rikke, hope you’re doing well.
Great to speak alongside Kath Sansom & Kieran Harkin in the Oireachtas audiovisual room, outlining the need for sunshine legislation: legally mandated public disclosure of payments from pharmaceutical and medical device company payments to healthcare professionals and healthcare organisations.
Congrats Maurice. Well deserved
Decorative Graphic
We are pleased to announce that applications are now open for the New Foundations Scheme. The scheme supports eligible researchers who intend to pursue research, networking or dissemination activities within and across the diversity of disciplines. Go to: researchireland.ie/funding/new-foundations/
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds.
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds.
We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.
shorturl.at/erwpH
@frankmoriarty.bsky.social @rcsi-research.bsky.social @rcsi.bsky.social @rcsipophealth.bsky.social
Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure
Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555
shorturl.at/l7OAh
Funded PhD opportunity at the University of Liverpool to explore the mental health and environmental impacts of outdoor advertising, focusing on meat and dairy
www.findaphd.com/phds/project...
$1000 per day for risdiplam from Roche for treatment of SMA.
Strange that that isn't on the poster either
@piotrjankol.bsky.social @robbielawlor.bsky.social @elstorreele.bsky.social @shaillygupta.bsky.social @markpetticrew.bsky.social @maizie333.bsky.social @imakglobal.bsky.social @tahiramin.bsky.social @hyoyoonkang.bsky.social @jamielove.bsky.social @ellenthoen.bsky.social @mbarber.bsky.social
